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ABSTRACT 
Peritoneal dialysis involves diffusive and convective transports and osmosis through the 
highly vascularized peritoneal membrane. The capillary endothelium offers the rate-limiting 
hindrance for solute and water transport. It can be functionally described in terms of a threepore 
model including transcellular, ultrasmall pores responsible for free-water transport 
during crystalloid osmosis. Several lines of evidence have demonstrated that the water 
channel aquaporin-1 (AQP1) corresponds to the ultrasmall pore located in endothelial cells. 
Studies in Aqp1 mice have shown that deletion of AQP1 is reflected by a 50% decrease in 
ultrafiltration and a disappearance of the sodium sieving. Haplo-insufficiency in AQP1 is also 
reflected by a significant attenuation of water transport. Conversely, studies in a rat model and 
in PD patients have shown that the induction of AQP1 in peritoneal capillaries by 
corticosteroids is reflected by increased water transport and ultrafiltration, without affecting 
the osmotic gradient and small solute transport. Recent data have demonstrated that a novel 
agonist of AQP1, predicted to stabilize the open state conformation of the channel, modulates 
water transport and improves ultrafiltration. Whether increasing the expression of AQP1 or 
gating the already existing channels would be clinically useful in PD patients remains to be 
investigated. 
 
 
The development of peritoneal dialysis (PD) as a successful therapy for patients with 
end stage renal disease has been paralleled by the need to understand the transport 
mechanisms operating in the peritoneal membrane. Functional alterations in the dialysis 
capacity of the membrane, leading to ultrafiltration failure, are associated with increased 
morbidity and mortality and represent a major obstacle to successful long-term PD therapy 
(1). Over the past three decades, investigations based on human and animal models provided 
significant insights into the physiology of transport pathways for water and solutes across the 
peritoneal membrane. Subsequent development of genetically modified mouse models yielded 
further insights and, in particular, molecular counterparts involved in peritoneal water 
transport (2). The purpose of this brief review is to discuss the current understanding of water 
transport mechanisms operating in the peritoneal membrane, and to delineate potential 
strategies to improve water transport and ultrafiltration in patients on PD. 
 
 
1. Structure of the peritoneal membrane 
The peritoneal cavity is lined by a thin, translucent membrane covering the inner 
surface of the abdominal wall and the majority of visceral organs, and also forming omenta. 
The peritoneal membrane (Fig. 1A) has a relatively large surface area (~1 m2) (3), a high 
degree of capillarization, and a relatively high blood flow (100-150 mL/min) in adults (4-6). 
The compact zone of the visceral peritoneum (that forms most of the peritoneal surface area) 
is about 20 m-thick in PD patients, whereas the parietal peritoneum can be thickened up to 
500 m in long-term PD patients, compared to 50 m in controls (7). 
The blood capillaries are distributed in a thin interstitium where their density is 
relatively high: for 1 m2 of peritoneal surface area and 200 m tissue depth, the total available 
capillary surface area is <2 m2 (8). The surface of the peritoneal membrane is lined by a 
continuous layer of flattened epithelial cells, the mesothelium (0.5-2 m thickness), covered 
with numerous microvilli. The mesothelium reduces the friction between visceral organs 
through the continuous production of lubricants, anticoagulants and surface tension lowering 
substances (8). 
The pathways available for solute and water exchange between the plasma in the 
peritoneal capillaries and the fluid in the peritoneal cavity include i) the continuous capillary 
endothelium; ii) the peritoneal interstitial space; and iii) the mesothelium. Of these potential 
barriers, it is the capillary endothelium that seems to offer the rate-limiting hindrance, 
restricting the solute exchange to less than 0.1% of its total surface area (4,8-10). Solutes 
larger than glucose are hindered in their transport across the permeable pathways (“pores”) of 
the capillary wall. The interstitium may also modify the transport of solutes across the 
peritoneal barrier, accounting for approximately 20-30% of the total diffusion resistance for a 
small solute (11). 
In the capillary wall (Fig. 1A, inset), the major route for small solute and fluid 
exchange is represented by the spaces in-between individual endothelial cells, the so-called 
interendothelial clefts (10). The functional radius of these clefts, denoted “small pores”, is 
~40-50 Å, i.e. slightly larger than the radius of albumin (36 Å). The small pores markedly 
impede the transit of albumin (by at least three orders of magnitude) and completely prevent 
the passage of larger molecules, such as immunoglobulins and 〈2-macroglobulin, across the 
capillary endothelium. However, large proteins can permeate to the interstitium (and the 
peritoneal cavity) via very rare transendothelial “large pore” pathways (radius ~250 Å) (12). 
These large pores account for only 0.01% of the total population of capillary pores and 
transport across them occurs by hydrostatic pressure-driven unidirectional filtration from the 
plasma to the peritoneal cavity. In addition, the capillary wall has a high permeability to 
osmotic water transport through ultrasmall, water-only pores of radius ~2.5 Å present in the 
endothelial cell membrane (13,14). 
 
 
2. The three-pore model 
The major principles governing solute and fluid transport across the peritoneal 
membrane are i) diffusion, driven by a concentration gradient according to principles 
originally described by Adolph Fick (15); and ii) convection, i.e. ultrafiltration driven by 
osmotic or hydrostatic pressure gradients. Osmosis is a phenomenon that occurs through a 
barrier restricting the transport of solute compared to that of water. If water is allowed to pass 
the barrier, while the solute is reflected, then the solute in solution will exert an osmotic 
pressure across the barrier (19.3 mmHg per 1 mM of solute), promoting water movement into 
the solution. If the solute is permeable across the barrier, the osmotic force exerted by the 
solute will be dependent upon the fractional reflection of solute by the barrier, described by 
the so-called osmotic reflection coefficient (⌠). A ⌠ value of 1.0 denotes the total reflection of 
solute in the barrier, whereas a ⌠ value of 0 characterizes a fully permeable solute. For small 
plasma solutes, reflection coefficients across the capillary wall in most continuous capillaries 
(cf. muscle, fat, connective tissue, peritoneum etc.) have classically been considered to be 
<0.1 (10). 
The continuous endothelium lining the peritoneal capillaries can be functionally 
described in terms of a three-pore model (TPM) (16,17). In the TPM, approximately 90% of 
the peritoneal UF-coefficient (LpS), and 99.5% of the total pore area available for solute 
transport, is accounted for by small pores, and 5-8% by large pores, occupying <0.5% of the 
total pore area. Only 2% of the LpS is accounted for by ultrasmall pores (Fig. 1A, inset). The 
small pores represent the major transport pathway for small solutes and water in the peritoneal 
membrane. Across these pores the so-called Starling equilibrium, i.e. the balance between the 
transcapillary hydrostatic pressure gradient (_P) and the opposing effective colloid osmotic 
pressure gradient (⌠prot_ prot; where ⌠prot is ~0.95), is established, where _P normally slightly 
outweighs ⌠prot_ prot. 
Normally, under non-PD conditions, ~60% of the net capillary UF occurs through 
small pores, which are largely protein-restrictive, and here _P and ⌠prot_ prot approximately 
balance out. Across large pores, as much as 40% of the total transcapillary UF occurs, and 
here _P totally dominates over ⌠prot_ prot, the latter being very low in large pores (because 
here ⌠prot is low). Only 1-2% of the total peritoneal water transport occurs via the ultrasmall, 
water-only pores under normal, non-PD, conditions (Fig. 1B). During conditions of PD, fluid 
removal can be markedly enhanced by the presence of an osmotic agent in the peritoneal 
cavity. The type of osmotic agent utilized markedly affects the mechanisms of osmosis. Very 
small osmotic agents (e.g. glycerol, with a Stokes-Einstein (SE)-radius ~3 Å) will exert a low 
osmotic effect on the small pores, and thereby act primarily on water-only pores (Fig. 1B). 
Glucose (SE-radius ~3.7 Å) will induce fluid flows, which are about equally partitioned 
among ultrasmall and small pores. High MW osmotic agents, such as polyglucose (SE-radius 
~15-20 Å), will remove fluid mainly via the small pores (Fig. 1B). Glucose osmosis will 
result in a rapid dilution of the peritoneal dialysate due to ultrasmall pore-mediated water 
flow, as reflected by a fall in dialysate sodium concentration during the first 2 h of the dwell 
(denoted “sodium sieving”). Furthermore, under PD conditions, the Starling forces “balance” 
is markedly shifted across the small pores. Indeed, _P has now been markedly reduced, due to 
the increased intraperitoneal hydrostatic pressure in PD, whereas _ prot has been markedly 
increased, due to a fall in peritoneal (tissue) colloid osmotic pressure as a consequence of the 
washout of interstitial proteins by the colloid-free PD fluid. Hence, after the glucose osmotic 
gradient has dissipated after ~4 h of the dwell, fluid will be reabsorbed through the small pore 
pathway from the peritoneal cavity to the plasma by the Starling mechanism (18) (Fig. 1B). 
Recent research has taken the modeling of peritoneal transport beyond the simple 
TPM. The simplest extension of the TPM is the so-called serial three-pore membrane/fiber 
matrix model that includes the interstitial (submesothelial) space as a serial transport 
resistance acting in concert with the capillary wall (11). More advanced simulations include 
not only the interstitium but also the distributed nature of the peritoneal capillary barrier in the 
modeling (19,20). These models exhibit a considerably higher share of capillary aquaporins 
(〈c), higher small solute ⌠:s, and a lower peritoneal LpS than predicted by the original TPM. 
This model, however, is problematic when it comes to computer simulating the osmotic 
behavior of oncotic agents, such as Icodextrin. The reason is that the difference in ⌠ between 
Icodextrin and small solutes (glucose) will then become too low to make Icodextrin 
osmotically efficient. Furthermore, with the low LpS of the distributed model, the oncotic 
(Starling pressure mediated) fluid reabsorption directly into the capillaries will become almost 
negligible and has to be replaced by a bulk (lymphatic) reabsorption term. Indeed, in a recent 
computer TPM simulation test, in which the capillary Starling reabsorption of fluid was not 
specifically accounted for, higher small solute ⌠:s, a higher 〈c, and a lower value for LpS than 
in the original TPM were obtained (21). This is in agreement with theoretical predictions 
(from the TPM) for the case when the Starling induced capillary fluid reabsorption is 
artificially diminished, by e.g. reducing the value for LpS (below 0.06 ml/min/mmHg) (22). 
 
 
3. Aquaporin-1 is the ultrasmall pore of the peritoneal membrane 
The identification of aquaporin-1 (AQP1), a 28 kD protein abundantly expressed in 
the kidney and red blood cells, as the first member of the aquaporin family (23, for review) 
had a major relevance for understanding the mechanisms of water transport and ultrafiltration 
in PD (Fig. 2A-B). Aquaporin-1 is a water-specific membrane channel, impermeable to urea 
and glycerol, that is distributed in many different cell types including the endothelium lining 
peritoneal capillaries and post-capillary venules (24). AQP1 is organized as a homotetramer, 
with each monomer containing six membrane-spanning 〈-helices forming a right-handed 
twisted arrangement surrounding a hourglass-shaped central pore. The atomic model of AQP1 
(Figure 2C), derived from studies based on electron and X-ray crystallography, revealed key 
features accounting for the high permeation rate (3 billions water molecules per second) and 
the strict selectivity of the channel for water (25). The selectivity of the AQP1 pore is ensured 
by a narrow constriction of <3 Å diameter (which accommodates a single water molecule, 2.8 
Å). Two hydrophilic loops (B and E), each containing a conserved NPA (Asn-Pro-Ala) motif 
and a short helix, bend into the cavity formed by the six helices. The N termini of these two 
short 〈 helices point into the aqueous pore and create a positive electrostatic field that 
orientates the water molecules to form hydrogen bonds with the two Asn residues (Asn76 and 
Asn192) that extend their amino groups into the lumen of the channel. This mechanism is 
breaking the string of hydrogen bonded water molecules through the pore, thus preventing the 
transport of protons. A transient reorientation of the water dipole occurs at that level, resulting 
from the hydrogen bonding with the Asn residues. A second constriction involves Arg195, 
which provides a strong positive charge at the narrowest region of the pore, with His180 and 
Phe56 (25). The central pore formed by each AQP1 monomer perfectly fits the postulated size 
of the ultrasmall pore of the peritoneal membrane. Of interest is the location of the side chain 
of a cysteine residue (Cys189) in the pore, explaining why the water permeability mediated 
by AQP1 is inhibited by mercury compounds (23). 
The functional relevance of AQP1 for PD was first suggested by ex vivo inhibition of 
peritoneal water permeability by HgCl2 in a rat model (13). Studies conducted in the Aqp1 
knock-out (KO) mice demonstrated that the osmotically-driven water transport across the 
peritoneal membrane was significantly decreased in Aqp1-/- mice, as compared with wild-type 
littermates (26). These data were extended by Ni et al. (14), who used a standard peritoneal 
exchange test (PET) with hypertonic glucose to demonstrate that AQP1-null mice had a <50% 
decrease in cumulative ultrafiltration during PD, and no evidence for sodium sieving, 
confirming the predictions of the TPM (Fig. 3). Heterozygous Aqp1+/- mice showed an 
intermediate phenotype, suggesting that haplo-insufficiency in AQP1 is reflected by 
significant attenuation of water flux and intraperitoneal volume curves. Of note, the deletion 
of AQP1 had no effect on the structure of the peritoneal membrane, the transport of small 
solutes and the magnitude of the osmotic gradient (14). 
To date, 13 members of the AQP family have been identified in mammals, with 
specific expression patterns and distinct roles in given tissues and cells. AQP1 is the most 
abundant isoform in the peritoneum, and the only one that has been consistently located in the 
capillary endothelium. It must be noted that the expression of AQP1 in mesothelial, 
endothelial and epithelial cells may be induced by exposure to osmotic agents in vitro, 
reflecting the presence of hypertonicity response elements in the promoter (27,28). Because 
the mesothelium does not represent a significant functional barrier for water transport in PD, 
the functional importance of water channels at that level remains unclear. 
 
 
4. Aquaporin-1 in ultrafiltration failure 
Ultrafiltration failure in long-term PD is usually associated with an increment in small solute 
transport combined with reductions in the osmotic fluid transport across the peritoneum 
(11,29). These alterations are not compatible with just an “increased vascular surface area”, 
i.e. an increased peritoneal vascularization, which would increase both the glucose osmotic 
efficiency, i.e. the glucose osmotic conductance (product of the peritoneal UF-coefficient, 
LpS, and the glucose reflection coefficient, ⌠g), and the rate of dissipation of the glucose 
osmotic gradient across the peritoneum during the dwell (30). By contrast, there seems to be 
an uncoupling between changes in the mass transfer area coefficient (MTAC) to glucose, and 
the changes occurring in LpS in these conditions (11). The unchanging, or even reduced, LpS 
in long-term PD has by some authors been attributed to reductions in AQP1-meditated water 
transport (31). However, a more likely explanation for these changes is that a combination of 
 
two processes, namely i) increases in the vascularization of the peritoneum; and ii) the 
production of fibrotic scar tissue in the peritoneum, have occurred in parallel (2). It can be 
shown that a combination of these two processes will actually tend to reduce the osmotic 
conductance to glucose (mostly LpS, but also ⌠g) while the MTAC to glucose will tend to 
increase (due to increases in peritoneal capillary density) (11,30). In fact, overall, there is an 
increase, and not a reduction, in the abundance of AQP1 in the peritoneal membrane in 
typical ultrafiltration failure - as pointed in the detailed case study of Goffin et al. (32). It is 
thus hypothesized that the interstitial fibrosis per se accounts for the reduction in 
transperitoneal UF, across both small and ultrasmall pores via a reduction in total LpS (31-33). 
One should stress, however, that mechanisms of ultrafiltration failure probably differ in shortvs. 
long-term PD patients (31) and may also include rare instances of increased absorption of 
fluid from the peritoneal cavity (34). 
 
 
5. Regulation of aquaporin-1 expression to increase ultrafiltration 
The fact that AQP1 is the molecular counterpart of the ultrasmall pore, mediating half 
of the ultrafiltration volume during crystalloid osmosis, suggested that it could be a target to 
modulate water transport in PD. The proof-of-principle for that concept was provided by a 
study in a rat model of PD (35). Knowing that the expression of AQP1 in the perinatal rat 
lung is induced by corticosteroids and that the promoter of the AQP1 gene contains 
glucocorticoid response elements (GREs), Stoenoiu et al. showed that a treatment of rats with 
dexamethasone (1 to 4 mg/kg BW) for 5 days was associated with an increased expression of 
AQP1 in the capillary endothelium. In turn, this induction was reflected by a significant 
increase in water transport and net ultrafiltration across the membrane. These modifications 
were observed in absence of any effect on the osmotic gradient or small solute transport (35). 
More recently, de Arteaga et al. reported serial determinations of water and solute transport 
parameters across the peritoneal membrane (mini PET) in three PD patients that received 
high-dose glucocorticoids (cumulative dose of methylprednisolone: 1.0–1.2 g/m2) as standard 
care after a living-donor renal transplantation (36). As compared with pre-transplantation, the 
post-transplantation PET evidenced an ∼2-fold increase in the sodium sieving (and its 
surrogate marker the absolute dip of dialysate sodium concentration), paralleled by an 
increase in the ultrasmall pore-specific UF. In contrast, the small solute transport rate, as 
assessed by the D/P creatinine and small pore-specific ultrafiltration, was unchanged. The 
potential role of the GRE-mediated effect on AQP1 was substantiated by demonstrating the 
expression of the glucorticoid receptor in the capillary endothelium of the human peritoneum 
(36). These data were the first to support the effect of corticosteroids on AQP1-mediated 
water transport in PD patients. Although these results have to be confirmed in a larger patient 
cohort and take into account the systemic effects of high-dose steroid administration, the 
specificity of the changes in free water transport suggests that pharmacologic induction of 
AQP1 may help to increase water transport in patients treated by PD. Future investigations 
should provide a better understanding of the regulators of AQP1 expression, the time-course 
of such regulation, and the potential effect of such regulators in different cell types expressing 
AQP1 (2). 
 
 
6. Pharmacological agonists of the aquaporins 
Beyond the possibility to induce the expression of AQP1 in peritoneal capillaries, an 
equally exciting opportunity is the search for pharmacological agonists of aquaporins, which 
would bind reversibly to the channel to further facilitate water transport. This possibility 
implies that aquaporins can be gated, i.e. they are not constitutively locked into a rigid open 
state. For instance, the lens water channel AQP0 as well as plant aquaporins show changes in 
water permeability as a function of pH (37,38). By extension, some aquaporins may have both 
open and closed state conformations, with overall water permeability at a given time 
reflecting the relative proportion of the channels in the open state. Stabilization of the open 
state conformation by ligand binding would then yield agonist activity. 
Mechanisms of gating of aquaporin channels are being defined. Intracellular domains 
have been proposed to gate channel functions in AQP1 (39,40) and the closely related AQP4 
(41). Aquaporins are highly conserved in animals and plants. A tight regulation of their 
aquaporins allows plants to cope with fluctuations in water supply during drought stress or 
flooding. Tornroth-Horsefield and colleagues used structural modeling to outline a detailed 
mechanism of gating in a spinach plasma membrane aquaporin (42). In this model, loop D is a 
hydrophobic barrier that caps and occludes the intracellular side of the water pore, in response 
to dephosphorylation of conserved serine residues or, alternatively, to the protonation of a 
conserved histidine (flooding stress). Interaction with the N-terminal domain and Ca2+ 
binding help to anchor loop D into the cytoplasmic pore vestibule, occluding the water 
channel. In the open conformation, the loop D is displaced after phosphorylation of the 
conserved serine residues, which induces rearrangement of residues that coordinate Ca2+ ion 
binding, disrupting the stabilizing interaction between loop D and the N terminus, and 
opening the hydrophobic gate (42). 
Modulators of AQP1 have been slow to emerge. Antagonists of AQP1 and AQP4 have 
been described, with a focus on arylsulfonamide compounds including the carbonic anhydrase 
inhibitor acetazolamide (43) and derivatives of the loop diuretic bumetanide (44). Of 
particular interest, a 4-aminopyridine carboxamide derivative of the loop diuretic bumetanide 
(AqB013) was shown to inhibit AQP1 in vitro by acting at an intracellular side that occludes 
the water pore (44). Docking simulations have identified two potential intracellular binding 
sites in AQP4, one being positioned in the water pore vestibule whereas the second is in a 
separate intracellular pocket that involves residues from the C-terminus and intracellular loop 
(44). This second site, which has a potential for allosteric regulation of the pore, has also been 
associated with regulation of AQP1 by cGMP (39), protein kinase C (40) and Ca2+ (45). 
Recent work has identified the first known aquaporin pharmacological agonist, 
AqF026, a chemical derivative of the arylsulfonamide compound furosemide (46) (Fig. 4A). 
In the Xenopus laevis oocyte system, extracellularly applied AqF026 at 5-20 M potentiated 
water channel activity of human AQP1 by more than 20%, but had no effect on AQP4 water 
channel activity. The intracellular binding site for AQP1, predicted by theoretical docking and 
tested by site-directed mutagenesis and swelling assays, involves the loop D which is known 
to be associated with channel gating. In vivo assays in a mouse model of PD (Fig. 4B-D) 
confirmed that AqF026 enhanced the osmotic water transport and net ultrafiltration across the 
peritoneal membrane without detectable effect on the osmotic gradient, the transport of small 
solutes, and the plasma membrane localization and expression levels of AQP1. Absence of 
potentiation effects of AqF026 in Aqp1-null mice further indicated that indirect mechanisms 
involving other channels or transporters were unlikely. The first identification of an aquaporin 
agonist able to increase osmotic water transport in vivo offers perspectives for PD and clinical 
situations associated with defective water handling (46). 
 
Conclusions and perspectives 
Transcellular water permeability mediated by AQP1 is an essential component of the 
water removal across the peritoneal membrane during peritoneal dialysis. Several lines of 
evidence have demonstrated that AQP1 is the ultrasmall, water-specific pore predicted by the 
TPM. Studies in the AQP1 KO mice demonstrated a strict correlation between AQP1 
abundance and solute-free water transport across the peritoneal membrane. They also 
confirmed that AQP1 is responsible for approximately 50% of the ultrafiltration when using a 
crystalloid osmotic agent such as glucose, and that AQP1 expression is necessary to observe 
the sodium sieving (14). By extension, the availability of the Aqp1 mouse model is useful to 
test the properties of alternative osmotic agents, as recently demonstrated for L-carnitine (47), 
or combinations of such agents. 
The studies outlined above support the validity of the TPM, which can now be tested 
against a simple and validated mouse model (48) allowing direct measurement of free-water 
transport in conditions of modified expression and, potentially, gating of AQP1. Assessing 
water transport across the peritoneum has already been shown to be useful for in vivo 
investigations of drugs or molecular pathways regulating AQP1 (35,36,47). Whether 
biochemical modifications of AQP1 (e.g. S-nitrosylation or abnormal glycation) may alter the 
integrity of the water pore and contribute to ultrafiltration failure remains unsolved (31,32). 
Similarly, the potential influence of variants in the AQP1 gene encoding AQP1 in the 
individual variability in free-water transport at the start of PD remains to be defined. 
The identification of the ultrasmall pore offers the opportunity to modulate water 
transport in PD. Proof-of-principle studies in rat and mouse models (35,46) and in PD patients 
(36) have shown that such modulation can be achieved without modifying the osmotic 
gradient or the small solute transport. Whether increasing the expression of AQP1 in the 
peritoneal membrane or gating the already existing channels could be used to treat UF failure 
and overhydration in some PD patients remains to be investigated. The maximal increase of 
AQP1-mediated free-water transport will occur during the first part of the dwell, when the 
osmotic gradient is maximal. A potentiation of AQP1 could thus be transient (lasting a few 
hours in the dwell), but may be important in patients treated with short dwells. Such a benefit 
could be hampered by the lack of sodium removal in multiple, high tonicity rapid exchanges. 
However, combining an AQP agonist with a low sodium solution might resolve this potential 
issue. The translational potential of agonists of AQP1 should also integrate the potential role 
of water channels in endothelial cell proliferation (49). 
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LEGENDS TO FIGURES 
Figure 1. Structure of the peritoneal membrane and the three-pore model. 
A. Cross-section of the human parietal peritoneum stained for the water channel aquaporin-1. 
The peritoneal membrane contains three components : a layer of ciliated mesothelial cells (*), 
with microvilli and apical protrusions into the peritoneal cavity (#); the interstitial tissue 
containing bundles of collagen and mucopolysaccharides; a dense network of capillaries, 
blood vessels, and lymphatics. During peritoneal dialysis, the microvascular endothelium 
(arrows, stained in red) represents the functional barrier for the transport of solutes and water 
from the blood of the patient to the dialysate that has been instilled in the peritoneal cavity. 
Inset. The continuous endothelium lining the peritoneal capillaries can be functionally 
described as a three-pore model. The small pores (radius ~40-50 Å), located between the 
endothelial cells account for approximately 90% of the peritoneal UF-coefficient (LpS, or 
hydraulic conductance), and 99.5% of the total pore area available for solute transport. The 
large pores (radius ~250 Å), thought to correspond to interendothelial gaps, account for 5-8% 
of the LpS, occupying <0.5% of the total pore area. The ultrasmall pores (radius ~2.5 Å), 
wich account for only 2% of the LpS are the only ones to be located in the endothelial cells. 
The Starling forces (P, hydrostatic pressure; ∠, oncotic pressure) operating across each type 
of pore are indicated. r, functional radius; Å, angström (10-10 m). 
B. Transcapillary ultrafiltration in the three-pore model. 
a. Fractional fluid flows across the peritoneum under normal conditions with no dialysis. In 
absence of osmotic agent, ~60% of the transcapillary fluid flow occurs through small pores, 
where the Starling forces are close to equilibrium. Approximately 40% of the capillary UF 
occurs across large pores where there is hardly any colloid osmotic pressure counteracting the 
transcapillary hydrostatic pressure gradient. 
b. With glycerol (SE-radius ~3 Å) as osmotic agent, ~55% of the transperitoneal water flow 
will occur through water-only, ultrasmall pores and 45% through small pores. This is due to 
the relative inefficiency of glycerol as osmotic agent across the small pore pathway (⌠ ~0.02). 
c. With glucose (SE-radius ~3.7 Å) as osmotic agent ~45% of the transperitoneal water flow 
will occur through water-only pores and 55% through small pores. Although glucose is a 
relatively inefficient osmotic agent in the small pore pathway (⌠ ~0.03), it is 50% more 
efficient than glycerol. 
d. In a conventional Icodextrin PD solution, ~25-30% of the molecules (~3 mM) act as a 
colloid, implying a reflection coefficient close to unity. It should be noted that 3 mM of high 
MW icodextrin will produce a colloid osmotic pressure of ~58 mmHg (3 x 19.3 mmHg), 
which is sufficient to counteract the plasma colloid osmotic pressure (22-26 mmHg) exerted 
by approximately 1 mM of negatively charged plasma proteins. Note, that the partitioning of 
fluid flows among the different porous pathways in the TPM is now almost identical to that in 
the peritoneum occurring during high net UF conditions in the absence of crystalloid osmotic 
forces. 
e. Reabsorption of fluid across the small pores occurs when the crystalloid (glucose) osmotic 
gradient has totally dissipated (usually after 4 h). The net Starling fluid balance is biased 
toward reabsorption across the small pores in PD. Some fluid reabsorption will also occur 
across AQP1. Minute ultrafiltration still occurs across the large pores. 
Figure 2. Expression and distribution of AQP1 in the peritoneal membrane; structure of 
the water pore. 
A. Immunoblotting for AQP1 in human kidney (HK) and human peritoneal membrane (HPM) 
extracts. The signal for the core (28 kD) and glycosylated (35-50 kD) AQP1 is detected in the 
extracts, with lower expression levels in the peritoneal membrane. 
B. Immunogold electron microscopy on mouse visceral peritoneum unicryl sections shows a 
very strong signal for AQP1 in the plasma membrane and plasma membrane infoldings of 
capillary endothelial cells. Comparison of the labeling density in wild-type mice shows that 
AQP1 labeling is markedly stronger in endothelial cells than in red blood cells. (Bar, 500 nm). 
C. Structure and selectivity of the water pore of AQP1. The channel consists of an 
extracellular and a cytoplasmic vestibule connected by an extended narrow pore or selectivity 
filter. Four bound water molecules are localized within the selectivity filter, along three 
hydrophilic binding sites in the long hydrophobic pore segment. Residues of the constriction 
region, in particular Arg195, His180, Asn192 and Asn76, are critical in establishing water 
specificity and proton exclusion. For details, see text. (Modified from Ref. #25). 
Figure 3. Effect of AQP1 deletion on the transport of water across the peritoneal 
membrane. 
Mice with a targeted deletion of Aqp1 were investigated using a peritoneal equilibration test 
using hypertonic glucose. The cumulative ultrafiltration (2h-dwell, 7% glucose DianealR) is 
halved in AQP1-null mice vs. wild-type controls (A). In comparison with wild-type mice 
(squares), mice lacking AQP1 (circles) show a complete loss of sodium sieving (B). The 
intraperitoneal volume vs. time (V(t)) curves (C, obtained with 2.5 ml of 3.86% glucose 
DianealR containing 50 l of 10% bovine serum albumin and 50 l of 125I-human serum 
albumin) were also significantly lower in the Aqp1-/- mice (circles) compared to Aqp1+/+ mice 
(squares). Intermediate values of sodium sieving and intraperitoneal volume curves are 
observed in heterozygous Aqp1+/- mice. There were at least 5 mice matched for age and 
gender in each group. *P<0.05 vs Aqp1+/+ mice and #P<0.05 vs Aqp1+/- mice. 
(Modified from Ref. #14). 
Figure 4. AqF026, a novel agonist of AQP1, increases osmotic water transport in vivo. 
A. Chemical structure of AqF026 and the parent compound furosemide. 
B. Wild-type Aqp1+/+ mice treated with AqF026 have a significant, dose-dependent increase 
in net ultrafiltration (UF) across the peritoneal membrane. The maximal response is observed 
for a concentration of 15 μM, with an estimated EC50 value of 4.2 μM (inset). Aqp1-/- mice, 
characterized by a 60% reduction in UF at baseline, show no potentiation of the UF after 
treatment with 15 mM AqF026. Data are mean ± SEM; n=6 for each AqF026 concentration 
except for 0.75 μM (n=4). Net UF rates were standardised to body weight and compared with 
vehicle-treated mice (open bar). 
C. Treatment of Aqp1 
+/+ mice with 15 μM AqF026 results in increased intraperitoneal (IP) 
volume over time (p=0.016 between the AqF026 and vehicle curves), with significant 
differences at the 30, 60 and 90 min time-points in AqF026- (black triangles), as compared 
with vehicle-treated (open squares) animals (p<0.01, p<0.05 and p<0.05 respectively; n=10 in 
each group). 
D. The dialysate-to-plasma ratio of osmolality at 30 min (D/P osm) was similar in mice 
treated with 15mM AqF026 vs. vehicle (n=12 pairs of Aqp1 
+/+ mice). 
Data compiled from Ref 46, with permission. 
